First Three US Institutions Adopt Hominis Surgical Robotic System
Memic Innovative Surgery announced that three US institutions have acquired the Hominis robotic surgical system. Kendall Regional Medical Center of HCA Florida Healthcare, AdventHealth Celebration and the Women's Hospital at Jackson Memorial Hospital are the first US institutions to acquire the Hominis surgical system.
“It is important that healthcare systems and clinicians continue to invest in innovative and breakthrough technologies to offer patients superior medical care and optimal outcomes. Kendall is one of the busiest robotic surgery programs in South Florida, and we are proud to be among the first in the US to offer this new system, which allows us to perform minimally invasive gynecological procedures using transvaginal access, which is known to offer less pain, lower infection rates, faster recovery and no visible scarring”
Israeli Memic Hominis system will now be used at the institutions for single-port transvaginal benign gynecological surgeries with laparoscopic assistance through natural orifices, including benign hysterectomy.
“As a leader in robotic surgery, we always strive to provide our community with innovative and advanced technologies to improve the efficiency of surgical techniques and emphasize our shared commitment to whole-person health care. This technology will allow us to perform surgical procedures that are impossible today and improve the surgical experience for a wide range of patients”
The company markets Hominis as the first and only FDA-approved surgical robot with miniature humanoid arms featuring shoulder, elbow and wrist joints that provide human-level dexterity and 360-degree articulation.
“As one of the most advanced surgical centers in the region, we are delighted to add new technologies and surgical solutions that will benefit our patients. We are proud to be among the first in the country to offer this new scarless surgery, and we look forward to changing the lives of our patients in South Florida”
Memic, which in August 2021 confirmed plans to become a public company through a merger with a SPAC, developed the Hominis system to reproduce the movements and capabilities of a surgeon's hands, requiring smaller size and lower costs than conventional robotic systems.
The system received FDA clearance in February 2021. In April 2021 it raised $96 million in funding.
“We are proud to work with these leading healthcare providers to give surgeons the best user experience and help them better serve the thousands of women who undergo gynecological surgery each year. These sites create a strong foundation for expanding Hominis adoption in the market, including a leading advanced robotic surgery center, a 450-bed hospital owned by one of the largest US hospital systems, and a 1,550-bed nonprofit teaching hospital affiliated with a well-known medical school. With their support, we are expanding our commercial presence to increase reach of our patented technology and make a positive impact in the Florida region and beyond, as we work to expand Hominis adoption worldwide”
Founded in 2013 and headquartered in Tel Aviv, Israel, Memic is a medical device company transforming surgery with its patented surgical robotic technology.
Memic aims to transform robotic surgery with patented technology that could significantly surpass today's best solutions.
Its Memic Hominis surgical platform, offering unprecedented access and maneuverability, is equipped with miniature humanoid robotic arms with human dexterity, superhuman flexibility and the ability to rotate 360 degrees.
In addition to these features, the system will be sold at a significantly lower price than other robotic surgery systems on the market, potentially allowing more healthcare facilities, including hospitals and ambulatory surgery centers, to access and adopt surgical robotics.
In addition to current transvaginal applications, Memic continues to develop the technology to explore its use in single- and multi-port abdominal surgery, as well as other transluminal indications.
